Cargando…

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity

BACKGROUND: High density lipoprotein (HDL) particles are heterogeneous in composition, structure, size, and may differ in conferring protection against cardiovascular disease. HDL associated enzyme, paraoxonase-1 (PON1), has an important role in attenuation of atherogenic low density lipoprotein (LD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Razavi, Amirnader Emami, Ani, Mohsen, Pourfarzam, Morteza, Naderi, Gholam Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702082/ https://www.ncbi.nlm.nih.gov/pubmed/23833575

Ejemplares similares

Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein
por: Boshtam, Maryam, et al.
Publicado: (2013)

Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients
por: Basati, Gholam, et al.
Publicado: (2011)

Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
por: Beekhof, Piet K, et al.
Publicado: (2012)

A retrospective institutional study of histopathologic pattern of Oral Squamous Cell Carcinoma (OSCC) in Tehran, Iran during 2006-2015
por: Ghafari, Ramin, et al.
Publicado: (2019)

Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010)

The Relationship between Daily Fructose Consumption and Oxidized Low-Density Lipoprotein and Low-Density Lipoprotein Particle Size in Children with Obesity
por: Gungor, Ali, et al.
Publicado: (2021)

Functionally Defective High-Density Lipoprotein and Paraoxonase: A Couple for Endothelial Dysfunction in Atherosclerosis
por: Eren, Esin, et al.
Publicado: (2013)

Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
por: Kim, Dal-Sik, et al.
Publicado: (2010)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Dietary Squalene Increases High Density Lipoprotein-Cholesterol and Paraoxonase 1 and Decreases Oxidative Stress in Mice
por: Gabás-Rivera, Clara, et al.
Publicado: (2014)

Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer
por: Khaleghian, Malihea, et al.
Publicado: (2016)

Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases
por: Arab, Zahra Najafi, et al.
Publicado: (2022)

Evaluation of Paraoxonase, Malondialdehyde, and Lipoprotein Levels in Patients with Asymptomatic Cholelithiasis
por: Atamer, Aytac, et al.
Publicado: (2014)

Adiponectin and Lipoprotein Particle Size
por: Weiss, Ram, et al.
Publicado: (2009)

The Effect of Insulin Resistance and Obesity on Low−Density Lipoprotein Particle Size in Children
por: Taşcılar, Mehmet Emre, et al.
Publicado: (2010)

The Relation between Polymorphisms in Exon 5 and Exon 6 of GSTP1 Gene and the Risk of Lung Cancer in Iranian People
por: Shahsavari, Gholamreza, et al.
Publicado: (2019)

Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
por: Mastorikou, M, et al.
Publicado: (2008)

Impact of the 24-h ultramarathon race on homocysteine, oxidized low-density lipoprotein, and paraoxonase 1 levels in professional runners
por: Benedetti, Serena, et al.
Publicado: (2018)

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2019)

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
por: Tanaka, Sébastien, et al.
Publicado: (2019)

Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice
por: Charles-Schoeman, Christina, et al.
Publicado: (2020)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Hemoglobin level and lipoprotein particle size
por: Hämäläinen, Päivi, et al.
Publicado: (2018)

Association between the Expression Levels of MicroRNA-101, -103, and -29a with Autotaxin and Lysophosphatidic Acid Receptor 2 Expression in Gastric Cancer Patients
por: Tutunchi, Sara, et al.
Publicado: (2022)

The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
por: Moshtaghie, Elham, et al.
Publicado: (2022)

Association between triglyceride-glucose index and low-density lipoprotein particle size in korean obese adults
por: Kim, Sanghoon, et al.
Publicado: (2023)

A 90 minute soccer match decreases triglyceride and low density lipoprotein but not high-density lipoprotein and cholesterol levels
por: Rahnama, Nader, et al.
Publicado: (2009)

Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2019)

HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression
por: Mirmohseni Namini, Nazanin, et al.
Publicado: (2021)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes
por: Tian, Li, et al.
Publicado: (2012)

Low-Density-Lipoprotein Particle Size Predicts a Poor Outcome in Patients with Atherothrombotic Stroke
por: Song, Tae-Jin, et al.
Publicado: (2015)

Effect of Lycopene Application in Rats with Experimental Diabetes Using Lipoprotein, Paraoxonase and Cytokines
por: Yegin, Sevim Çiftçi, et al.
Publicado: (2013)

Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
por: Agilli, Mehmet, et al.
Publicado: (2014)

Serum Paraoxonase as an Indicator for Fatty Liver in Sheep
por: Cao, Yu, et al.
Publicado: (2017)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome
por: Furuyama, Fumiaki, et al.
Publicado: (2018)

Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice
por: Zhao, Xiao-Jie, et al.
Publicado: (2021)

Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease(*)
por: Samsamshariat, Saedziaaldin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gqbd1qihr2sob1o869cf5khlq4